Mark Adams is an internationally renowned and respected authority in healthcare management with over 35 years of CEO experience in the UK, USA, and throughout the GCC.
Mark Adams is CEO of Community Integrated Care, one of Britain’s biggest and most successful social care charities. The charity, which turns over £140m annually, supports almost 4000 people who have learning disabilities, autism, mental health concerns, and dementia. It has a workforce of 6500 people.
Community Integrated Care is nationally recognized as being one of the most innovative providers in the market, with significant sector recognition – including being named as the 2019/20 Charity Times Charity of the Year for its impact and innovation.
He is currently also a Non-Executive Director for the National Care Forum, a leading representative body for the not-for-profit care sector which brings together 115 members, as well as the Countess of Chester NHS Foundation Trust in the North West of England.
He also sits on the Board of Directors of John Hopkins Aramco Healthcare in the Kingdom of Saudi Arabia.
Mark has an extensive background in the healthcare and commercial industries. This includes CEO and senior Board roles with leading organizations, including Denplan, AXA PPP, Virgin Healthcare, Vitality Healthcare, and Netcare UK, He has also had a decade leading large healthcare organizations in the Middle East. This includes forming Anglo Arabian Healthcare (AAH), an integrated network of 40 clinics, diagnostic centers, hospitals, pharmacies, and other specialist services that became one of the biggest operators in Dubai.
Mark has led start-up Healthcare Operations, PE-backed buy and build as well as listed companies in the UK, America and across the Gulf Council Countries. Mark has led companies ranging from Denplan and AXA PPP to Virgin Healthcare and the South African owned Netcare UK as well as startup ventures and Publicly Listed Companies.
As the chairman of the General Authority of Healthcare Accreditation and Regulation in Egypt, Dr. Ismail leads Egypt’s strategy in adopting and organizing healthcare for all healthcare facilities and workers.
Dr. Ismail has worked for more than 40 years in the healthcare field. With an international career spanning 25 years internationally, he has a plethora of experience in accrediting hospitals, managing healthcare quality, improving performance, and developing human resources for health. His contributions to quality education and training in post-university education are well known.
Dr. Ismail was appointed by the Joint Commission International as General Director of its Middle East branch in March 2009. Over a period of ten years, he led the efforts of the Joint Commission International in the region and achieved tremendous success in increasing the number of accredited institutions from 50 accredited institutions in 2009 to 370 accredited institutions in 2019. During this period, Joint Commission International became the gold standard for accreditation all over the world.
As an assistant professor at the George Mason University School of Health and Human Services, he has taught a variety of quality courses to obtain a degree in Quality and Results Management. Dr. Ismail is also a WHO consultant on accreditation and quality of healthcare.
In 2006, he was chosen as a strategic planning consultant to the Minister of Health of the United Arab Emirates in order to develop a new strategy for the health sector. As a quality consultant, he assisted healthcare facilities in the accreditation process. His experience in these areas extended from the United States of America to the Middle East. For four years, he worked as a quality consultant for the Innova Health System, the largest health system in Northern Virginia.
As a faculty member at Johns Hopkins University and director of the Regional Bureau for Asia/Near East/Europe for the Johns Hopkins Obstetrics and Gynecology Education Program, he led efforts to implement family planning, reproductive health, and development of USAID-funded human resources projects in 14 countries in the region.
While working with the United States Agency for International Development in Cairo as a director of medical programs, he implemented with the Egyptian government the largest family planning program at the level of Egypt, established the Regional Center for Training in Family Planning and Reproductive Health at Ain Shams University and presented the first national program to improve quality in family planning clinics In Egypt.
Dr. Claudia Mika is the Founder and CEO of Temos International Healthcare Accreditation, a German-based international accreditation body that was founded in 2010 as a spin-off of a European research project.
Dr. Mika brings years of dedication to developing accreditation standards and improving the Temos accreditation programs, assessing hospitals, clinics, rehabilitation centers, reproductive care centers, and dental clinics worldwide. Having worked globally with healthcare providers, she has the first-hand experience in building quality management systems as well as risk management programs from Brazil to the Philippines. With her team of experts in clinical and non-clinical services, Dr. Mika has created accreditation programs for hospitals and clinics that cater to domestic and international patients across a wide spectrum of healthcare disciplines. She actively participates in the accreditation process, spending time with clients to share her years of experience with the Continuous Quality Improvement process that is at the heart of successful accreditation.
Her commitment to quality outcomes, governance and leadership, patient safety, risk reduction, and the patient experience as well as her track record for excellence and innovation is mirrored by the accreditation standards; always aiming at adding value for the users of the standards.
Between 1994 and 2010, Dr. Mika gained extensive experience in the management of international projects, when she took up different positions at the German Aerospace Center (DLR), a German governmental research organization. She planned, organized and evaluated international projects e.g., in Moscow, Russia, as a member of the “Head Down Tilt Study Group”. She further worked in space physiology projects like MIR’97 including the quality management and monitoring of standardized procedures for the astronauts on board. In 2002, Dr. Mika received the “Young Researcher Award” of the European Space Agency. She held various positions at the Institutes of Aerospace Medicine, both at DLR in Cologne and at the Technical University of Aachen, where Dr. Mika also worked in the Clinic of Child and Adolescent Psychiatry and Psychotherapy.
Dr. Mika is regularly invited to international Conferences and has trained a vast number of people on five continents as part of her Temos Academy activities. She held guest lectureships at PUCRS University in Porto Alegre, Brazil, and at the University Hospital in Aachen, Germany. She advises different associations and governmental institutions regarding quality-related topics, patient experience and risk management. She consulted the Turkish Ministry of Health by developing a guideline on quality assurance in international patient management. She is the Vice Chairwoman of the Diplomatic Council Healthcare Forum and has been giving workshops for several embassies worldwide.
She supported the 2018 Dubai Health Authority (DHA) Medical Tourism Conference as a member of the Scientific Board and has been a judge for the International Medical Travel Awards since 2013. In 2017, Dr. Mika was awarded the Dr. Sanjiv Malik Lifetime Award.
In 2019, Dr. Mika successfully spearheaded the rigorous process of submitting Temos standards for accreditation by the International Society for Quality in Health Care (ISQua now known as IEEA) to firmly cement Temos’ place among the world’s elite international accreditation organizations. In 2020, Dr. Mika developed together with her expert team a set of standards to help healthcare organizations worldwide to minimize the risk of COVID-19 transmission in healthcare settings.
Since January 2021 Dr. Mika has been a member of the Executive Committee of the European Fertility Society and also chairs the society’s Certification Committee.
Dato’ Dr Jacob Thomas, a medical doctor, has vast experience in hospital management, having served in various capacities at the Ramsay Sime Darby Health Care, including as the Executive Director of their Flagship Hospital, Subang Jaya Medical Centre (SJMC) for 9 years from 1998 till 2006. He is currently the Chairman of the Board of Directors of Ramsay Sime Darby Health Care (RSDHC) Group, in addition to serving as the Group Medical Advisor of its six hospitals in Malaysia and Indonesia and recently a Day Surgery Centre in Hong Kong. RSDHC is a leading tertiary care medical group in the region, reputed for its quality medical care and service excellence.
Dr Jacob Thomas is currently a past President of the Association of Private Hospitals of Malaysia (APHM) after having held the post of President from 2008 till 2018. He was recently appointed by the Prime Minister of Malaysia as the Champion (Head) of the Private Healthcare Productivity Nexus under the Malaysia Productivity Corporation (MPC), which seeks to improve the productivity of the private healthcare sector in Malaysia. This also includes the must-awaited enhanced Public-Private Partnership.
He serves as a Councilor of the Malaysian Society for Quality in Health (MSQH), which is an accredited member of ISQua. He is, since 2014, a Board Member of the Joint Commission International (JCI) based in Chicago. Since January 2021, he has been appointed as the Chair of this prestigious Board. Dr Thomas today works closely with Malaysia Healthcare Travel Council (MHTC) and various Government agencies and NGOs to promote Malaysian Healthcare both locally and internationally.
Dr Jacob Thomas is today a much sort after speaker at many conferences and seminars both locally and Internationally. He also sits on the Editorial Board of many Healthcare Magazines and assists as an advisor and judges for regional Healthcare Conferences and Awards.
Recently, Dato Dr. Jacob Thomas was conferred the 2019 Lifetime Achievement Award for Healthcare by Global Health & Travel. This award is a testament to his contribution to the development of healthcare regionally.
Laila is the founder & CEO of Health Beyond Borders in Dubai. Health Beyond Borders is a bespoke Dubai-based health care advisory firm focused on the following services; Healthcare Strategy and Research, Health Investment Facilitation, Healthcare Marketing, and Business Development in UAE, Medical Tourism Consulting, and advising. HBB can help your business navigate through the challenges and leverage the opportunities and bring considerable economic benefit in a sustainable and effective manner.
Prior to this Laila was the CEO of the Health Policy and Strategy Sector at Dubai Health Authority (DHA).
She was responsible for the development of the policy and legislation for the health system in the Emirate of Dubai driven from the Dubai Strategic Plan (DSP). Overseeing the implementation of the DHA Health strategy and conducting sector planning and forecasting. She has extensive knowledge of the healthcare systems, Health reforms, strategic direction, planning, and delivery of healthcare services.
She was leading the process of Dubai health reform that took place in 2007 and responsible for the development of the Dubai Health Insurance Model in 2009. Laila also was leading the Dubai medical tourism initiative which was launched in 2012 to place Dubai on the world health tourism map.
Laila is a graduate from the College of Allied Health Science, Kuwait University, and secured her Masters in Executive Healthcare Administration with honorary from Zayed University in affiliation with the State University of Arizona. She is a graduate of Sheikh Mohammed Bin Rashid Executive Leadership Program and Sheikh Rashid Award for Scientific Outstanding.
Laila was also awarded the Feigenbaum Excellence Leadership Award for “Women’s leaders”. Recently she is been awarded as one of the 50 “GCC Women leaders” by World CSR Day & World Sustainability in Dubai. Also, Laila has been awarded as one of the 50 Women in Health Care & Wellness in Mumbai, and one of the World’s Greatest Women Achievers by URS Asia One. Laila is a member of the Board of Governors for Rak Medical & Health Sciences University as well as Dubai Pakistan Association for non for profit. She is also a member of the Global Health Travel Council since 2013.
Dr. Salamah is the Treasurer and Corporate Secretary of the Board of Directors and the Chief Executive Officer of the Foundation. He is a highly motivated international healthcare leader who has demonstrated sound business judgment, decisiveness, well-developed planning, strong leadership, and a consistently high level of performance in a variety of progressively responsible and challenging assignments.
In his most recent role, he was the International Manager of the JCI Office in the Middle East, he was responsible for 74 countries across Africa and Asia. In his capacity, he worked very closely with health care organizations, ministries of health, governments and international aid agencies, leading academic medical centers and hospitals, healthcare leaders, and other organizations across the region to build and manage strategic partnerships with those who are committed to improving healthcare quality and patient safety.
He is very well known by many Healthcare international Leaders as being a man of principles who dedicated most of his career to improving the quality of healthcare services and helps reshape the future of the industry.
Dr. Salamah spent more than 15 years in healthcare business development within big multinational corporations like Pfizer, Novo Nordisk, Eli Lilly Suisse, and Johnson and Johnson. He served in different leadership positions. Working in very tough and competitive markets/industries with a consistent budget over achievement, complemented with outstanding creativity and innovation, was the reason behind the success he achieved. He has always shown strong commitment and passion towards developing people’s skills and competencies, due to his strong belief in the power of individuals.
Prior to JCI, he was the Chief Executive Officer of a leading Healthcare Consultancy Firm; overseeing and developing technical, marketing, and financial feasibility studies for healthcare projects. His role extended to work with Public and Private Clients in 58 Countries to help raise funds for innovative projects. Prior to this, he was a Business Unit Director in one of the leading medical supply companies in the UAE. In this capacity, he managed a portfolio of 400 products, more than 2000 SKUs. He successfully over-delivered a budget of 110 Million USD.
Dr. Salamah is a recognized trainer who has delivered more than 150 training courses to big organizations, he believes that every human being is capable of learning and I also believe that every human being possesses a genuine desire to learn, but he learns differently and that when taught in a way that is conducive to his unique learning style, learning can always be achieved. The successful trainers whom he met during the last 25 years have some attributes in common; they used to present their subjects in a simple and attractive way, they used to clarify difficulties, they put knowledge into context and they used to build relations with their trainees upon respect and love. These models have influenced his training abilities greatly.
Born and raised in Wallasey, Merseyside. Educated at Wallasey Grammar School (1959/65)
After leaving school in 1965, joined Martins Bank (taken over by Barclays in 1968) and then moved in 1969 to Royal Insurance 1969 -91
In 1984 Personal computing was in its infancy and he was invited to organize training on the first IBM PCs. In finding a niche he then founded Royal Insurance Education Services (RIES) to not only organize training within the
The company but also (following acceptance at Board Level in 1987) to market training on a commercial basis. This became hugely successful and RIES became the first Authorised Microsoft IT Applications training center in the UK and the first Lotus 1-2-3 UK Training Centre also. Simultaneously he founded MERIT (Merseyside Information Technology) to bring together IT expertise across the region. MERIT was supported by the regional government and also became very successful in running for 21 years. MERIT was a forerunner to TLC.
VNG Group 1991-5 – Divisional Managing Director. Four successful years but VNG was hit with the then recession and sold.
BroadSkill 1996 – 2014
Mr. Fletcher formed and founded BroadSkill in 1996 offering national IT training and solutions services. In 12 years we became one of the UK’s top IT Training companies working behind the scenes for many major organizations. BroadSkill was sold successfully in 2008 to Bray Leino. In the meantime, they developed an IT database to handle long-term healthcare issues. BroadCare became very successful and is now (within its sphere) de facto within NHS. Mr. Fletcher had taken the view that BroadCare would be better developed in a more focused environment and he identified CHS Healthcare as being the best new owner. Mr. Fletcher then retired as Managing Director of BroadCare in 2014, became Executive Chairman of CHS Healthcare. He negotiated and organized the sale of BroadCare to CHS then following completion decided to fully retire and focus on the development of The Leaders Club.
The Leaders Club (TLC)
Founded The Leaders Club www.theleadersclub.org in 2009 to bring together an eclectic group of people from a wide variety of disciplines to share and compare leadership experience. TLC has now had over 150 events and meeting monthly in mainly Liverpool and London. Running on the Chatham House rule, Its motto is Bringing Great Minds Together. It now has over 800 members. TLC has become hugely successful and meetings are now largely conducted via videoconferencing and attracting large numbers due to the width and breadth of the program. Mr. Flectcher is actively seeking to move TLC onto a truly international basis
Senior Fellow – Liverpool Hope University 2017-20
Mr. Fletcher was invited by Liverpool Hope University to become a Senior Fellow. Developed the Leaders Awards scheme for Liverpool City Region in conjunction with the University. The pandemic has clearly curtailed further activity and 2020 was well underway and in its 3rd year, Leaders are nominated, judged, and recognized in 6 categories – Arts, Education, Enterprise, Health & Social Care, Uniformed Services, and Common Good. The annual celebratory dinner was attended by over 150 guests. Unfortunately, a change in Pro-Vice-Chancellor has curtailed activities and he decided to resign his position.
Justice of the Peace
A huge privilege to become a Magistrate which is completely voluntary with its origins going back to 1215.
Appointed in 1984. Retired February 2018 – 34 years.
An eminent leader, Dr. Mohamed H. Sayegh served as the Raja N. Khuri Dean of the Faculty of Medicine and Executive Vice President of Medicine and Global Strategy at the American University of Beirut (AUB) from 2009 to 2020. Dr. Sayegh started his career path by obtaining his MD with distinction from the American University of Beirut in 1984. He then moved to the USA where he pursued the rest of his training and spent most of his academic career. In 1987, he completed his residency training in Internal Medicine at Cleveland Clinic Foundation in Ohio. By 1990, he completed his research and clinical fellowship in Renal Medicine and Transplantation Immunobiology at Harvard Medical School and the Brigham and Women’s Hospital in Boston. He then ascended the academic ranks at Harvard Medical School, from Instructor in 1990 to Assistant Professor in 1992, to Associate Professor in 1997, and Full Professor of Medicine in 2004. By 2005, he was awarded the Warren E. Grupe and John P. Merrill Endowed Chair in Transplantation Medicine at Harvard Medical School, and Director of the Schuster Family Transplantation Research Center at the Brigham and Women’s Hospital and Boston Children’s Hospital. He is currently (starting January 2020) the Special Advisor to the President for Medicine and Health at AUB focusing on new business development outside Lebanon. He also serves as the Senior Advisor on Research in the Middle East and North Africa at the National Institute of Allergy and Infectious Diseases (NIAID) / National Institutes of Health (NIH) to promote NIH-funded research in the MENA region.
Dr. Sayegh actively engaged in research and became internationally known as a world leader in transplantation, renal medicine, and transplantation immunobiology. As an investigator, Dr. Sayegh’s name appears in 359 journal publications. Since 1989, he has published 270 articles, 57 reviews, and 36 editorials in peer-reviewed journals. Among the 359 publications, he is the major contributor (First or Senior author) to 159 articles. Of the 159 articles where he is a major contributor, 128 are published in top-tier journals (Q1) in their respective discipline. Additionally, he published 41 book chapters, 8 textbooks/monographs, 50 proceedings of meetings, and established 19 patents. According to Scopus, his H-index is 95 and his total citations are 31,099. However, according to Google Scholar, his H-index is 110 and his total citations are 42,730.
In addition to his interest in research, Dr. Sayegh has extended his knowledge and experience in the scientific community by serving on several committees in various capacities. He served as Council Member and President (2000 – 2001) of the American Society of Transplantation (AST) and as the Chair of the Transplant Advisory Board of the American Society of Nephrology (ASN). A few years later, he served as the Chair of the AST Program, Education and Development Committees, as the Chair of the 2005 ASN Program Committee, the Chair of the Program Committee of the 2006 World Transplant Congress, and the 2007 World Congress of Nephrology. His efficiency and determination to progress further in his career led him to serve as co-chair of the Steering Committee of the NIH Immune Tolerance Network and a member of the Executive Committee. Subsequently, he was selected as Chair of the Steering Committee of the NIH consortium, Clinical Trials in Organ Transplantation (CTOT). He continues to provide ongoing editorial support as an ad-hoc reviewer for many prominent journals just NEJM, American Journals of Pathology, Kidney Transplantation, and Kidney Diseases, to name a few, and served as Editor-in-Chief for Organ Transplantation and held several editorial positions in many prominent journals.
Believing that leadership is about creating leaders, and in addition to his notable achievements, Dr. Sayegh proved to be a distinguished mentor with exceptional training skills when elected as a member of the ASCI, AAP, and FRCP. Under his direction, tens of investigators trained and grew to become active leaders in renal and transplant programs worldwide. In recognition of his exceptional efforts, he was awarded the 2008 First Mentoring Award of the AST.
Dr. Sayegh’s record of accomplishments encompasses many highly distinguished and prestigious awards and honors including:
1983 Alpha Omega Alpha
1984 MD Diploma with Distinction (Honors)
1989 UPJOHN Young Investigator Award, American Society of Transplant Physicians
1991 – 1992 Ortho-Grant-In-Aid Young Investigator Award, American Society of Transplant Physicians
1996 – 1999 Clinician Scientist Award, National Kidney Foundation
1997 First Young Scientist Award, Wyeth-Ayerst-American Society of Transplant Physicians
2008 First Mentoring Award, American Society of Transplantation
2008 NKF’s Shaul G. Massry Distinguished Lecture Award
2010 AST Basic Science Established Investigator Award (Professor Level)
2013 Gold Award, American University of Beirut Alumni Chapter
2014 Ben Qurrah Award, National Arab American Medical Association – Houston Chapter
2015 Fellow of the American Society of Transplantation
2018 Kuwait Foundation for the Advancement of Sciences (KFAS) Prize: Fundamental Sciences – Biological Sciences
Internationally, Dr. Sayegh held a number of leadership positions. He served as Chair of the Scientific Advisory Board and member of the Board of Trustees of the Harvard Dubai Foundation. Currently, he serves on the International Advisory Board for the Hamad Bin Khalifa University and Qatar Foundation. In addition, he is a Board of Trustee member with the University of Sharjah and a member of the Association of Academic Health Centers International (AAHCI) Steering Committee, the Regional Ambassador hosting the AAHCI MENA Regional Office at AUBMC, and the Chair Designate of AAHCI. He is also a member of the newly formed Academy of Arab Scientists of the Kuwait Foundation for the Advancement of Sciences of which he is the recipient of the KFAS prize. Credited for substantial and landmark contributions, Dr. Sayegh was elected into Arab Business’ 2011 and 2012 Power 500 – World’s Most Influential Arabs.
In July 2009, Dr. Sayegh returned to Lebanon and the American University of Beirut as Raja N. Khuri Dean of the Faculty of Medicine and the Executive Vice President for Medicine and Global Strategy. He envisioned and developed an ambitious and impactful plan for AUB’s Medical Center and healthcare in Lebanon and the region, known as the AUBMC 2020 Vision, adopted by the Board of Trustees in June 2010. AUBMC 2020 Vision encompasses propelling patient care, medical education, and research to new levels of excellence unprecedented in the Middle East region. This strategic vision, with clear goals and intricate implementation processes, has generated a significant amount of local, regional and global support. The realization of the AUBMC 2020 Vision has been witnessed in many ways. The successful model of recruitment and “reverse brain drain” is the first attestation to the success of the vision which has allowed the recruitment of over 200 faculty members back to Lebanon since the summer of 2009 to join AUBMC from leading academic medical centers throughout the world and be part of this pioneering vision. This model was published in “Nature Middle East” to be used as a guide for other entities in the region. Philanthropists have also shown their trust and support in the vision through unprecedented donations. Since 2009, during his tenure at AUB, Dr. Sayegh raised a total of $230 million to support the AUBMC 2020 Vision. The vision has also helped the Lebanese economy not only through the creation of jobs and donations but also through catalyzing other market sectors such as construction, contracting, manufacturers, amongst others, with the development of the AUBMC 2020 Medical Complex and the new buildings that are being erected. AUBMC is leading the way through the establishment of leading Centers of Excellence (CEOs) in areas that impact the people of our region the most with an integrated and multidisciplinary approach. The model of CEOs has bread group practices, encouraging faculty to sub-specialize and work together in a complementary fashion. This environment fosters cooperation, synergy, innovation, opportunities for additional faculty recruitment, advances in basic and clinical research, and comprehensive and specialized teaching, and training of the future leaders in medicine and healthcare.
In 2015, Dr. Sayegh was appointed as the Executive Vice President of Medicine and Global Strategy at the American University of Beirut. In this capacity and in view of the new Health 2025 Vision, the Strategic Health Initiatives (SHI) was announced by the AUB President as the starting step in the path for operationalizing AUB vision on health, unifying AUB Vision: health as a demonstration area and creating an interim participatory platform of engaging campus and AUBMC on the health theme – Health 2025. Since then, this strategy evolved towards a new plan for a Health Sciences Complex (HSC), serving as the first in the Arab region. An integral component of the HSC is the establishment of a new flagship unit, the Global Health Institute (GHI), the first such institute in the Middle East and North Africa (MENA) region. GHI serves as a hub for interdisciplinary research, capacity building, and dedicated service as well as an incubator for contextualized solutions to global health challenges emerging from the Global South. Finally, Dr. Sayegh is the sponsor and national ambassador of the United Nations Sustainable Development Goal number 3 (UN-SDG3, Good Health, and Wellness) and serves on the UN-SDG Council of Global Compact Network Lebanon.
Dr. Yasser Farahat currently serves as Professor of Urology at Tanta University, Egypt, a Clinical Tutor at Edinburg University, UK, and a Fellow of the Royal College of Surgeons, UK. He is a Consultant Urologist at the Ministry of Health and Prevention UAE and a Fellow of the European Board of Urology (FEBU). He is acting as a Senior Consultant of Urology at Sheikh Khalifa General Hospital (SKGH-UAQ), UAE.
His special interests & research include minimally invasive surgery, Endo-urology, Robotic Assisted FURS, Reconstructive Urology, and Andrology. He completed his MD in 2004 at Tanta University, Egypt. He had been awarded several prizes including the Best Research and Presentation at The First Eastern Mediterranean Meeting of European Association of Urology in 2007 and The Best Research Poster Presentation at the 25th annual EAU Congress in 2010.
He is one of the worldwide initiators of using the robotic-assisted RIRS since the invention of the Roboflex and improving the utilization of flexible ureteroscopy in renal calculi management.
He is also, a reviewer of several international journals. He has published over 35 international and local publications and has presented at 90 conferences worldwide.
Dr. Farahat is an active member of many international urological associations and societies including, The European Association of Urology (EAU), Société Internationale D’Urologie (SIU), Endourological Society and he is currently the head of the scientific committee of Emirates Urological Society (EUS), Cochair of the scientific committee of Urological Association of Asia (UAA), Secretary-General of Arab Association of Urology (AAU) and Chairman of Arab School of Urology.